Botanical Identity Testing: FTIR, HPTLC, DNA Barcoding and the Orthogonal-Method Bar for Supplement Ingredients
21 CFR 111.75 requires identity testing on every component used in a dietary supplement. For chemically defined ingredients (synthetic vitamins, minerals, amino acids) a single appropriate scientifically valid method is usually sufficient. For botanicals — root powders, leaf extracts, standardised extracts, herbal blends — single-method identity testing is no longer the defensible bar. FDA's botanical guidance, NSF/ANSI 455-2, USP general chapters and the wider scientific community have converged on the orthogonal-method principle: a chemical fingerprint (FTIR, HPTLC, NIR, HPLC), plus a morphological or genetic confirmation (macro/microscopy, DNA barcoding), so that a substitution or adulteration that defeats one method is caught by the other. This guide maps the orthogonal-method bar for botanicals and what each method actually proves.
Why single-method identity fails for botanicals — the adulteration economics
Chemical fingerprint methods — FTIR, NIR, HPTLC, HPLC
Morphological and genetic methods — macro/microscopy and DNA barcoding
Choosing the orthogonal pair — by botanical and by ingredient form
Operating posture — supplier qualification, in-house vs contract lab, and trending
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Two methods on the spec, both required before release.
AHP / USP authenticated references, version-controlled.
Adulteration drift visible early, not after a Warning Letter.
Frequently asked
Does the FDA require two identity tests for botanicals?
When is DNA barcoding the wrong tool?
Why is HPTLC preferred over HPLC for some botanicals?
Can I rely on supplier COAs for identity?
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
- 10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- 21 CFR 211 Drug cGMP Readiness Guide
- 21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
- 21 CFR 589 BSE / Ruminant Feed Ban Readiness Guide
- 21 CFR 820 to ISO 13485 Mapping Guide (Including QMSR Harmonisation)
